Frontlight ResearchEarly access
Trial site
Medical Research Center of Connecticut, LLC
- 3running trials
- 5closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease5 trials
- Ulcerative colitis3 trials
- Asthma1 trial
- Eosinophilic oesophagitis1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 42 trials
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Lead sponsor
- Takeda3 trials
- Eli Lilly and Company2 trials
- Agomab Spain S.L.U.1 trial
- Ellodi Pharmaceuticals, LP1 trial
- Hoffmann-La Roche1 trial
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
Closed trials
Completed
Completed
Completed
24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026